Aptevo Therapeutics Inc (NASDAQ:APVO)
| 0.3015 BATS BZX Real-Time Price As of 9:32am ET |  -0.0385 / -11.32%Today’s Change | 0.30 Today|||52-Week Range 7.20 | -87.00% Year-to-Date |
Latest APVO News | Press Releases
No recent news for Aptevo Therapeutics Inc.
Today’s Trading
| Previous close | 0.34 |
| Today’s open | 0.31 |
| Day’s range | 0.30 - 0.31 |
| Volume | 792 |
| Average volume (3 months) | 248,903 |
| Market cap | $3.9M |
Data as of 9:32am ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -327.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -74.67% |
| P/E ratio | NM |
| Price/Sales | 3.80 |
| Price/Book | 0.12 |
Competitors
| ---- | ||
| MODCModern Technology Co... | 0.00 | 0.00% |
| CYTOAltamira Therapeutic... | -0.01 | -3.02% |
| CFRXContraFect Corp | +0.01 | +2.05% |
Data as of 1:43pm ET, 09/25/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$1.16 |
| Annual revenue (last year) | $3.1M |
| Annual profit (last year) | $8.0M |
| Net profit margin | 225.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
